Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bulls certainly underestimated how many pathetic and unscrupulous CosmeticMDs exist in aesthetics but many injectors are stocking Daxxify and I see new practices announcing it daily.
The ugliest thing is the competition and their proxies are rallying around stopping RVNC’s progress. If the injectors avoid stocking Daxxi, that is not good.
Q1 is never a good qtr for most bioland stocks. don't expect that to be diff here. and ceo has said so in prior comments. i think key is keeping the same 2024 overall guidance even w/ soft q1 #s (which i expect). and maybe, just maybe in Q2 or Q3 ER, they can actually beat the guidance and/or raise 2024 overall #s. that would be something. i don't think Q1 # by itself means much as long as overall 2024 # is in tact or even higher than $280 guidance.. (of course if lower guidance, then sure, we will lose even the $3 handle maybe), but i am here for 4-6 qtrs as this will take a lot of time to play out
if q1 numbers don't fit into that $280 million EOY revenue picture, it will get much uglier. We will know soon enough.
w/ RVNC, not a stock you want to be watching tick by tick every day. that will make LT holders suicidal. i have been in RVNC for years (did exit a couple of times too), and recently entered, and I knew this would be a very long turnaround, if at all. i think we get Q1 ER out of the way (nothing special prob.) and need to see Q2 and Q3 to be the pivot point to turn this around. usually before that happens, share price would have bottomed well beforehand. i think 3.7 today would turn out to be the bottom.
Will also be buying $3ish print today as well as currently offering out 50 puts @ $2.5 strike(Oct 18th expire) …
I thought the same, for 40M big fish can take 10% of MC and clean house.
Another issue i see is SG&A for Revence - similar revenue to Evolus but $130M more expenses.
This company would be a good target for an activist investor to get involved in. I'm pretty sure investors wouldn't support the current board.
all of a sudden now that $6.25 raise looks phenomenal
Therapeutics might be the only way out of this mess.
Well, closed under $4/share. Some day RVNC will stop going down. I just hope it is before it gets to zero. 🤣
A little gallows humor.
Those are ancillary data on retreatment intervals from the ASPEN-1 and ASPEN–OLS trials. Worth knowing, but not market-moving.
I’m sure the data presented are positive for Daxxi and Revance, but this data won’t move the stock.
Is any body expecting positive data on Daxxify from the conference currently taking place: https://ih.advfn.com/stock-market/NASDAQ/revance-therapeutics-RVNC/stock-news/93643006/revance-to-present-new-daxxify-data-at-the-americ
Yes sir, agreed..mainly it’s regarding 3rd Tranche, and if he can share any color( which is doubtful, but never know til you ask) or do we have to wait for Q1 CC…Will update if anything meaningful
Just an example, there is a Med Spa doctor in the Mid Atlantic and she makes $140,000 plus annually published on the Sunshine Act as a speaker for Botox/Juvederm. My guess is the practice also get $40,000 to $60,000 in free staff training products which are sold to patients at full price. This type of bribery goes on all across the USA with dozens of injectors.
This Med Spa doctor will not even see the RVNC rep!!!
Pretty sure this is the same Laurence( his says New Street) that is the contact person, but just him VM and start repore
Investors
Laurence Watts, 619-916-7620
laurence@newstreetir.com
Some aesthetics practices may genuinely not be offering Daxxify because they were turned off by their interactions with their Revance sales rep or management but that doesn't really pass the smell test. It's clear many unscrupulous CosmeticMDs are being compensated financially by Abbvie/Galderma one way or another to steer their patients towards the legacy toxins and maintain the status quo. In therapeutics payers will have a very strong incentive to switch patients to the best toxin with the best price (Daxxify) and the doctors don't have a conflict of interest that violates their Hippocratic oath.
The new IR firm (#msg-174240308) should be able to answer any question that Jessica could.
RVNC IR is_now_handled_by Gilmartin Group, which has an impressive client list:
https://gilmartinir.com/clients/clients-overview/
The clients are listed in alphabetical order; scan down to see the full list. To see only the biotech clients, click on the “Biotechnology” tab.
Wow, I was thinking same question if she can share without recourse by HR…after losing Jessica, I lost a good contact that could answer some simple , legal questions ..
I know Foley was 100% involved with ALL the bad decisions and he should be fired like any other CEO who has made terrible decisions. Foley is 100% a hatchet man, and my guess is that is why the Board kept him. Foley has loyalty only to his own paycheck! Foley is there for one reason, to bring the company into profit and sell it!
Sadly, RVNC is 100% a manipulated stock by the shorts...would not be surprised is AbbVie is shorting RVNC....Hopefully, Foley will get the Sxxt out of his mouth and make some type of positive announcement soon to change the course of the SP.
Ms.D,
Thank You for all the Insightful Information and although you put your employment on the line( ie-if “HR”alerted—not suggesting anything nefarious nor insider trading, whistleblow) I / we appreciate what you’re going thru!!!!
… and as an investor who is also down ~$350k+ (main account), I hope you continue and thrive at Revance..sadly the majority of my ‘circle’ of friends
(Palm Beaches, perhaps the most plastic place on earth other than Bev Hills, etc.) never have heard of Daxxy!! And although my 2 buds own the most successful practice’s here, they offer but seemingly not major supporters of the product ( at first it was the pricing, then duration claims) and now most disturbingly Foley/Management!!! I’m trying to touch base with them again to see if Foley is personally reaching out( especially to the larger of the 2 who boasted about his ‘friendship and respect/admiration) for him but had since waned :(
Curious, in your humble and noticeably informed opinion, is there another internal candidate, or perhaps more probable a person outside who could replace Foley?? Any internal ‘cooler’ discussions that you can share without recourse?
Thanks again and keep the faith, one way or another, many of US believe the company will prosper with or w/out Mark!!!!
GLTA
I thought you didn't like what Foley was doing to RVNC, like just two posts ago. Anything that happened in the meantime that made you change your mind?
The positive side is RVNC will survive and Daxi will be available for both aesthetic and therapeutic patients. Daxi will provide superior outcomes to many patients which the #1 goal in our medical world. The Aesthetic World will see faster onset, longer duration, improved skin tone and better profitability.. The Therapeutic World will see faster onset, longer duration, less side effects from spread to the toxin and lower cost to the patient, provider and payer. These competitive advantages will be the factors and forces which grow Daxi sales.
The Negative side is Foley is and has to bring the "expense element" of RVNC in line with sales revenues. Aesthetic Daxi will continue to gain market share as the aesthetic team builds and converts injectors to Daxi with the benefits of Daxi and the additional profits that Daxi generates for the practice. Aesthetic injectors are all about profits. Therapeutic Daxi will soon be available and selling which will continue to build market presence. Therapeutic doctors are all about providing patients with the best medical product to treat the patient's condition. International Daxi sales will also begin. And there is also the Generic Botox element which is coming soon,
Foley had to and is cutting costs in anyway possible in an effort to match revenues and expenses to create a profitable RVNC. From the communications on this board it appears Foley is doing just that. Share price will recover and begin to go up as soon as investors realize and see how RNVC has been rebuilt. Foley is a hatchet man going into a company that was destine run out of cash and is now rebuilding the infra-structure to match sales and will come out a shining star.
Well leadership doesn’t communicate. All we have to go by is who is here to support product marketing and launches.
We no longer have a team to support Daxxify aesthetics relaunch efforts, we have no staff to launch therapeutics for CD. Everyone is gone - IR and Comms teams resigned. Media, PR, and investor relations has been outsourced. Not a great indicator.
I’m referring to previous posts regarding the mall events and Erica posing in front of a wrapped vehicle. Those were not successful events by any stretch. This is just social media marketing.
There are plenty of organic social posts that are real and are favorable from top Derms and injectors.
Hi. Answering your question about stock grants. I’m referring to vested stock units as part of negotiated signing compensation, vested stock units that were grants (still as negotiated compensation in lieu of annual raises) and employee purchased stock. The first two are earned as part of compensation and in my case I paid $48k for employee purchase stock over a period of 4 years that grew exponentially. We could not sell these during long black out periods. I also have Restricted Stock units that have not vested that aren’t worth much at this point.
I don’t think of this as a freebie or a windfall. It’s deferred compensation and money I earned and invested. 😞
<<< Instagram - I’ve yet to see a *recent* Instagram of either a patient or injector who made reference to fact that initially they had problems, but decided to give it another try with a more experienced injector and it worked great. >>> SMH. Why would either a patient or injector make a video like that? Makes absolute zero sense. You want an injector to say... I'm an idiot and didn't know what I was doing, but now I do? Or you want a patient to say I went to a really bad injector but then found a new injector who knows what they are doing?
Instagram - I’ve yet to see a *recent* Instagram of either a patient or injector who made reference to fact that initially they had problems, but decided to give it another try with a more experienced injector and it worked great.
Revance is going to need a lot more of this (above) kind of patient or injector.
Do you see it turning around?
You say,
I agree they could sell it for $8 for sure but they won’t unless they have been lying to investors
Don’t think we have disagreements on this
RVNC is a tragic story - cash hemorrhaging launch strategy in aesthetics that good & experienced people knew wouldn’t work. Self dealing and massive ego trips. Daxi could be positioned as THE workhorse toxin for aesthetic practices, paired with a workhorse filler line. Instead… investors got “prestige.”
Therapeutic is everything.
What?? Are you actually saying a person must try the products a company sells before having an opinion? Wow!! Does that apply only to RVNC or is it for every company?
Yes… without a doubt Daxxi is an exceptional product. Tested experts vouch for its effectiveness, the high quality results and patient satisfaction. Experience with Daxxi is growing… with that, demand for the product will grow. The Genie is out of the bottle.
Thanks for the post.
Followers
|
147
|
Posters
|
|
Posts (Today)
|
3
|
Posts (Total)
|
7049
|
Created
|
02/09/14
|
Type
|
Free
|
Moderators DewDiligence |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |